Friday, July 10, 2026

pharma · 2019-nCoV Pneumonia

Tongji Hospital

Tongji Hospital clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
1
Drugs
1
Patents
0
Intelligence · Clinical Programs

Tongji Hospital projects

1 ClinicalTrials.gov programs sponsored by Tongji Hospital.

Tongji Hospital has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. ASC09F+Oseltamivir

    Tongji Hospital

    2019-nCoV Pneumonia

    phase 3 small molecule active

    1 trial

Frequently asked questions

How many clinical projects does Tongji Hospital have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.